Apoptosis Assays Market Size, Opportunities, Key Growth Factors, Revenue Analysis Till 2027
The global apoptosis assays market size valued of USD 2.99 billion in 2017 and is expected to register a CAGR of 9.4% during the forecast period.
Increasing
R&D expenses and growing cell-based research are expected to drive the
growth of the market. On the other hand, required high investment for research
activities can restrain the market growth over the assessment period. Recently,
in 2016, the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem
Cell Research and the Stein Eye Institute received USD 5.1 million from the
California Institute for Regenerative Medicine. This funding helps for the
development of novel therapy for blinding retinal conditions. Furthermore, the
National Institutes of Health (NIH) invested USD 1.65 billion for stem cell
research in 2017. This funding drives the growth of the apoptosis assays
market.
Regional
Analysis:
Geographically,
the Americas is expected to dominate the global market owing to the presence of
well-established players and increasing funding for cell
apoptosis assay. Europe is expected to hold the second largest position in
the global market. Asia-Pacific is expected to be the fastest growing market.
Furthermore, the Middle Eastern and African region is expected to account for
the least market share in the global market.
Segmentation:
The global
apoptosis assays market has been segmented into product, detection technology,
application, and end user.
Based on
product, the market is segmented into kits, reagents, instruments, and others.
The kits segment accounted for the largest share and fastest growing segment of
the global apoptosis assays market in 2017.
Based on
detection technology, the market is segmented into flow cytometry, fluorescence
microscopy, western blot assessment, gel electrophoresis, and others. The flow
cytometry segment accounted for the largest share segment of the global
apoptosis assays market in 2017.
Based on
application, the market has been segmented into drug discovery and development,
stem cell research, and others. The drug discovery and development segment
accounted for the largest share of the global apoptosis assays market in 2017.
The stem cell research was the fastest growing segment of the global apoptosis
assays market in 2017.
Based on
end user, the market has been segmented into pharmaceutical and biological
companies, research institutes, and others. The pharmaceutical and biological
companies segment accounted for the largest share of the global apoptosis
assays market in 2017. Research institutes were the fastest growing segment of
the global apoptosis assays market in 2017.
Key
Players:
Some of the
prominent players in the global apoptosis assays market are Abcom plc (US),
Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US),
GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company
(US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and
Promega Corporation (US).
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment